Market by Type, Application, End-user, and Regional Outlook | Forecast 2021-2028
Triton Market Research predicts that the global botulinum toxin market is anticipated to rise with a CAGR of 5.55% during the forecast period 2021-2028. The market was valued at $2327.91 million in the year 2020, and is expected to rise to a revenue of about $4744.35 million by the year 2028.
Triton’s report on the
botulinum toxin market provides an in-depth insight into the market. The
detailed analysis of the market includes key market insights, Porter’s five
forces analysis, key impact analysis, and market attractiveness index.
Factors such as the increasing
demand for aesthetic procedures and the expansion of botulinum toxin into
therapeutic applications are expected to foster the growth of the market during
the forecast period. The demand for aesthetic procedures is increasing, and it
is expected to continue to grow in the near future. Moreover, there is an
increase in people’s concern regarding their appearance in developed as well as
developing regions. Furthermore, the rising awareness regarding various
cosmetic procedures to reduce aging signs, especially in women, is expected to
drive market growth.
Furthermore, the increasing
aging population and rise in medical tourism are expected to act as some opportunities
for the market. There are continuous advancements in the medical field
aesthetics, which help the aging population to live a healthy, more active, and
enjoy a younger lifestyle. Botulinum toxin has been known to give patients a
more youthful appearance, and new studies show that it can actually slow down
the aging process. Therefore, the increase in the aging population results in
the growth of the market.
The upgrades and continuous changes in reimbursement policies act as restraining factors for the botulinum toxin market. The current trend of healthcare, reimbursement, coverage reform, payer & provider consolidation, and escalating healthcare costs will allow lesser adoption to the newer advanced botulinum toxin products and impede the market’s growth. Furthermore, the adverse effects associated with botulinum toxin and the lack of interchangeability between botulinum toxin products are some of the key restraining factors of the botulinum toxin market.
Key
geographies covered in the global botulinum toxin market are:
• North America: United States and Canada
• Europe: United Kingdom, France, Germany, Spain, Italy,
Russia, and Rest of Europe
• Asia-Pacific: China, Japan, India, Australia, South Korea,
ASEAN Countries, and Rest of Asia-Pacific
• Latin America: Brazil, Mexico, and Rest of Latin America
• Middle East and Africa: Saudi Arabia, Turkey, United Arab
Emirates, South Africa, and Rest of Middle East & Africa
The
segmentation analysis of the botulinum toxin market includes:
• Type is sub-segmented into:
o Type
A
o Type
B
• Application is sub-segmented into:
o Cosmetic
Applications
• Glabellar
Lines
• Lateral
Canthal Lines (Crow’s Feet)
• Forehead
Lines
• Other
Cosmetic Applications
o Non-cosmetic
Applications
• Dystonia
• Chronic
Migraine
• Ophthalmologic
Disorders
• Other
Non-Cosmetic Applications
• End-users is sub segmented into:
o Hospitals
o Clinics
and Others
The
key companies profiled in the report include Evolus Inc, Revance Therapeutics
Inc, Ipsen Pharma, Hugel Inc, Galderma Pharma SA (Acquired By EQT), Medytox
Inc, Abbvie Inc (Allergan Plc), US WorldMeds LLC, and Merz Pharma.
Market By Type, Application, E ..
VIEW REPORT
Market By Offerings, Technolog ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT1. GLOBAL
BOTULINUM TOXIN MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. KEY
INSIGHTS
2.1.1. SURGE
IN DISPOSABLE INCOME
2.1.2. GROWING
NUMBER OF MEN OPTING FOR COSMETIC TREATMENT
2.1.3. DEVELOPMENT
OF HEALTHCARE INFRASTRUCTURE
2.2. IMPACT
OF COVID-19 ON THE BOTULINUM TOXIN INDUSTRY
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF SUPPLIERS
2.3.4. BARGAINING
POWER OF BUYERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS MATRIX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. NEW
PRODUCT LAUNCHES
2.7. MARKET
DRIVERS
2.7.1. INCREASING
DEMAND FOR AESTHETIC PROCEDURES
2.7.2. EXPANSION
OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS
2.8. MARKET
RESTRAINTS
2.8.1. ADVERSE
EFFECTS ASSOCIATED WITH BOTULINUM TOXIN
2.8.2. LACK
OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
2.8.3. LACK
OF INTERCHANGEABILITY BETWEEN BOTULINUM TOXIN PRODUCTS
2.9. MARKET
OPPORTUNITIES
2.9.1. INCREASING
AGING POPULATION
2.9.2. RISE
IN MEDICAL TOURISM
3. GLOBAL
BOTULINUM TOXIN MARKET – BY TYPE
3.1. TYPE A
3.2. TYPE B
4. GLOBAL
BOTULINUM TOXIN MARKET – BY APPLICATION
4.1. COSMETIC
APPLICATIONS
4.1.1. GLABELLAR
LINES
4.1.2. LATERAL
CANTHAL LINES (CROW’S FEET)
4.1.3. FOREHEAD
LINES
4.1.4. OTHER
COSMETIC APPLICATIONS
4.2. NON-COSMETIC
APPLICATIONS
4.2.1. DYSTONIA
4.2.2. CHRONIC
MIGRAINE
4.2.3. OPHTHALMOLOGIC
DISORDERS
4.2.4. OTHER
NON-COSMETIC APPLICATIONS
5. GLOBAL
BOTULINUM TOXIN MARKET – BY END-USER
5.1. HOSPITALS
5.2. CLINICS
AND OTHERS
6. GLOBAL
BOTULINUM TOXIN MARKET – REGIONAL OUTLOOK
6.1. NORTH
AMERICA
6.1.1. MARKET
BY TYPE
6.1.2. MARKET
BY APPLICATION
6.1.2.1. MARKET
BY COSMETIC APPLICATIONS
6.1.2.2. MARKET
BY NON-COSMETIC APPLICATIONS
6.1.3. MARKET
BY END-USER
6.1.4. COUNTRY
ANALYSIS
6.1.4.1. UNITED
STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET
BY TYPE
6.2.2. MARKET
BY APPLICATION
6.2.2.1. MARKET
BY COSMETIC APPLICATIONS
6.2.2.2. MARKET
BY NON-COSMETIC APPLICATIONS
6.2.3. MARKET
BY END-USER
6.2.4. COUNTRY
ANALYSIS
6.2.4.1. UNITED
KINGDOM
6.2.4.2. GERMANY
6.2.4.3. FRANCE
6.2.4.4. SPAIN
6.2.4.5. ITALY
6.2.4.6. RUSSIA
6.2.4.7. REST
OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET
BY TYPE
6.3.2. MARKET
BY APPLICATION
6.3.2.1. MARKET
BY COSMETIC APPLICATIONS
6.3.2.2. MARKET
BY NON-COSMETIC APPLICATIONS
6.3.3. MARKET
BY END-USER
6.3.4. COUNTRY
ANALYSIS
6.3.4.1. CHINA
6.3.4.2. JAPAN
6.3.4.3. INDIA
6.3.4.4. SOUTH
KOREA
6.3.4.5. ASEAN
COUNTRIES
6.3.4.6. AUSTRALIA
& NEW ZEALAND
6.3.4.7. REST
OF ASIA-PACIFIC
6.4. LATIN
AMERICA
6.4.1. MARKET
BY TYPE
6.4.2. MARKET
BY APPLICATION
6.4.2.1. MARKET
BY COSMETIC APPLICATIONS
6.4.2.2. MARKET
BY NON-COSMETIC APPLICATIONS
6.4.3. MARKET
BY END-USER
6.4.4. COUNTRY
ANALYSIS
6.4.4.1. BRAZIL
6.4.4.2. MEXICO
6.4.4.3. REST
OF LATIN AMERICA
6.5. MIDDLE
EAST AND AFRICA
6.5.1. MARKET
BY TYPE
6.5.2. MARKET
BY APPLICATION
6.5.2.1. MARKET
BY COSMETIC APPLICATIONS
6.5.2.2. MARKET
BY NON-COSMETIC APPLICATIONS
6.5.3. MARKET
BY END-USER
6.5.4. COUNTRY
ANALYSIS
6.5.4.1. UNITED
ARAB EMIRATES
6.5.4.2. TURKEY
6.5.4.3. SAUDI
ARABIA
6.5.4.4. SOUTH
AFRICA
6.5.4.5. REST
OF MIDDLE EAST & AFRICA
7. COMPETITIVE
LANDSCAPE
7.1. ABBVIE
INC
7.2. EVOLUS
INC
7.3. GALDERMA
PHARMA SA (ACQUIRED BY EQT)
7.4. HUGEL
INC
7.5. IPSEN
PHARMA
7.6. MERZ
PHARMA
7.7. MEDYTOX
INC
7.8. REVANCE
THERAPEUTICS INC
7.9. US
WORLDMEDS LLC
8. METHODOLOGY
& SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: GLOBAL BOTULINUM
TOXIN MARKET, BY REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS
MATRIX
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF NEW PRODUCT
LAUNCHES
TABLE 5: GLOBAL BOTULINUM
TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 6: GLOBAL BOTULINUM
TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 7: GLOBAL BOTULINUM
TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
TABLE 8: GLOBAL BOTULINUM
TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
TABLE 9: GLOBAL BOTULINUM
TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL BOTULINUM
TOXIN MARKET, BY REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
TABLE 16: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 17: EUROPE BOTULINUM
TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 18: EUROPE BOTULINUM
TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 19: EUROPE BOTULINUM
TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 20: EUROPE BOTULINUM
TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
TABLE 21: EUROPE BOTULINUM
TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
TABLE 22: EUROPE BOTULINUM
TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 23: ASIA-PACIFIC
BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 24: ASIA-PACIFIC
BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 25: ASIA-PACIFIC
BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 26: ASIA-PACIFIC
BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
TABLE 27: ASIA-PACIFIC
BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
TABLE 28: ASIA-PACIFIC
BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 29: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 30: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 31: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 32: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
TABLE 33: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
TABLE 34: LATIN AMERICA
BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 35: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 36: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 37: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 38: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $
MILLION)
TABLE 39: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $
MILLION)
TABLE 40: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCES
ANALYSIS
FIGURE 2: GLOBAL BOTULINUM
TOXIN MARKET, BY TYPE, 2020 & 2028 (IN %)
FIGURE 3: GLOBAL BOTULINUM
TOXIN MARKET, BY TYPE A, 2021-2028 (IN $ MILLION)
FIGURE 4: GLOBAL BOTULINUM
TOXIN MARKET, BY TYPE B, 2021-2028 (IN $ MILLION)
FIGURE 5: GLOBAL BOTULINUM
TOXIN MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 6: GLOBAL BOTULINUM
TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 7: GLOBAL BOTULINUM
TOXIN MARKET, BY GLABELLAR LINES, 2021-2028 (IN $ MILLION)
FIGURE 8: GLOBAL BOTULINUM
TOXIN MARKET, BY LATERAL CANTHAL LINES (CROW’S FEET), 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL BOTULINUM
TOXIN MARKET, BY FOREHEAD LINES, 2021-2028 (IN $ MILLION)
FIGURE 10: GLOBAL BOTULINUM
TOXIN MARKET, BY OTHER COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 11: GLOBAL BOTULINUM
TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 12: GLOBAL BOTULINUM
TOXIN MARKET, BY DYSTONIA, 2021-2028 (IN $ MILLION)
FIGURE 13: GLOBAL BOTULINUM
TOXIN MARKET, BY CHRONIC MIGRAINE, 2021-2028 (IN $ MILLION)
FIGURE 14: GLOBAL BOTULINUM
TOXIN MARKET, BY OPHTHALMOLOGIC DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 15: GLOBAL BOTULINUM
TOXIN MARKET, BY OTHER NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL BOTULINUM
TOXIN MARKET, BY END-USER, 2020 & 2028 (IN %)
FIGURE 17: GLOBAL BOTULINUM
TOXIN MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE 18: GLOBAL BOTULINUM
TOXIN MARKET, BY CLINICS AND OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 19: GLOBAL BOTULINUM
TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 20: UNITED STATES
BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 21: CANADA BOTULINUM
TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 22: UNITED KINGDOM
BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: GERMANY BOTULINUM
TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: FRANCE BOTULINUM
TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: SPAIN BOTULINUM
TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: ITALY BOTULINUM
TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: RUSSIA BOTULINUM
TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: REST OF EUROPE
BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 29: CHINA BOTULINUM
TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 30: JAPAN BOTULINUM
TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 31: INDIA BOTULINUM
TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 32: SOUTH KOREA
BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 33: ASEAN COUNTRIES
BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 34: AUSTRALIA & NEW
ZEALAND BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 35: REST OF
ASIA-PACIFIC BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 36: BRAZIL BOTULINUM
TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 37: MEXICO BOTULINUM
TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 38: REST OF LATIN
AMERICA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 39: UNITED ARAB
EMIRATES BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 40: TURKEY BOTULINUM
TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 41: SAUDI ARABIA
BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 42: SOUTH AFRICA
BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 43: REST OF MIDDLE EAST
& AFRICA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)